Literature DB >> 10699056

Why do women attend familial breast cancer clinics?

K Brain1, J Gray, P Norman, E Parsons, A Clarke, C Rogers, R Mansel, P Harper.   

Abstract

The increasing demand for genetic assessment for familial breast cancer has necessitated the development of cancer genetics services. However, little is known about the factors motivating the client population likely to approach these services. A cross sectional questionnaire survey of 1000 women with a family history of breast cancer was conducted to identify self-reported reasons for attending a familial breast cancer clinic and possible differences in the characteristics of women who were attending for diverse reasons. Before attendance at clinic, 833 women completed a baseline questionnaire (83% response rate). Women who gave personal risk (n=188), awareness of a family history (n=120), risk to family members (n=84), reassurance (n=69), genetic testing (n=65), breast screening (n=46), or prevention (n=39) as their main reason for attending were compared on demographic and medical variables, and on psychological variables including general anxiety, cancer worry, perceived risk, and attitudes towards prophylactic surgery and genetic testing. Important differences in the psychological characteristics of these groups were found, which were unrelated to reported family history. In particular, women who primarily wanted genetic testing felt extremely vulnerable to developing breast cancer, were more likely to be considering prophylactic surgery, and perceived fewer limitations of testing. Those who primarily wanted reassurance were highly anxious about the disease. We recommend that cancer genetics services take into consideration the informational and psychological needs and concerns of their client group.

Entities:  

Mesh:

Year:  2000        PMID: 10699056      PMCID: PMC1734549          DOI: 10.1136/jmg.37.3.197

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  23 in total

1.  The impact of mailing psychoeducational materials to women with abnormal mammograms.

Authors:  C Lerman; E Ross; A Boyce; P M Gorchov; R McLaughlin; B Rimer; P Engstrom
Journal:  Am J Public Health       Date:  1992-05       Impact factor: 9.308

Review 2.  Adherence and psychological adjustment among women at high risk for breast cancer.

Authors:  C Lerman; M Schwartz
Journal:  Breast Cancer Res Treat       Date:  1993-11       Impact factor: 4.872

Review 3.  Familial breast cancer.

Authors:  D G Evans; I S Fentiman; K McPherson; D Asbury; B A Ponder; A Howell
Journal:  BMJ       Date:  1994-01-15

4.  Psychological and behavioral implications of abnormal mammograms.

Authors:  C Lerman; B Trock; B K Rimer; A Boyce; C Jepson; P F Engstrom
Journal:  Ann Intern Med       Date:  1991-04-15       Impact factor: 25.391

5.  Linkage of early-onset familial breast cancer to chromosome 17q21.

Authors:  J M Hall; M K Lee; B Newman; J E Morrow; L A Anderson; B Huey; M C King
Journal:  Science       Date:  1990-12-21       Impact factor: 47.728

6.  DNA screening for breast/ovarian cancer susceptibility based on linked markers. A family study.

Authors:  H T Lynch; P Watson; T A Conway; J F Lynch; S M Slominski-Caster; S A Narod; J Feunteun; G Lenoir
Journal:  Arch Intern Med       Date:  1993-09-13

7.  Attitudes about genetic testing for breast-ovarian cancer susceptibility.

Authors:  C Lerman; M Daly; A Masny; A Balshem
Journal:  J Clin Oncol       Date:  1994-04       Impact factor: 44.544

8.  Telephone counseling improves adherence to colposcopy among lower-income minority women.

Authors:  C Lerman; P Hanjani; C Caputo; S Miller; E Delmoor; S Nolte; P Engstrom
Journal:  J Clin Oncol       Date:  1992-02       Impact factor: 44.544

9.  Psychological distress and surveillance behaviors of women with a family history of breast cancer.

Authors:  K M Kash; J C Holland; M S Halper; D G Miller
Journal:  J Natl Cancer Inst       Date:  1992-01-01       Impact factor: 13.506

10.  Perception of risk in women with a family history of breast cancer.

Authors:  D G Evans; L D Burnell; P Hopwood; A Howell
Journal:  Br J Cancer       Date:  1993-03       Impact factor: 7.640

View more
  39 in total

1.  To test or not to test? Moderators of the relationship between risk perceptions and interest in predictive genetic testing.

Authors:  Shoshana Shiloh; Shiri Ilan
Journal:  J Behav Med       Date:  2005-09-30

2.  Psychosocial conditions of women awaiting genetic counseling: a population-based study.

Authors:  Ellen M Mikkelsen; Lone Sunde; Christoffer Johansen; Søren P Johnsen
Journal:  J Genet Couns       Date:  2008-02-07       Impact factor: 2.537

3.  Identifying outcomes of clinical genetic services: qualitative evidence and methodological considerations.

Authors:  Christalla Pithara
Journal:  J Genet Couns       Date:  2013-09-14       Impact factor: 2.537

Review 4.  Cancers related to genetic mutations: important psychosocial issues for Canadian family physicians.

Authors:  Tara E Power; John Robinson
Journal:  Can Fam Physician       Date:  2006-11       Impact factor: 3.275

5.  A pre-visit tailored website enhances counselees' realistic expectations and knowledge and fulfils information needs for breast cancer genetic counselling.

Authors:  Akke Albada; Sandra van Dulmen; Dick Lindhout; Jozien M Bensing; Margreet G E M Ausems
Journal:  Fam Cancer       Date:  2012-03       Impact factor: 2.375

6.  Factors associated with an individuals' decision to withdraw from genetic counseling for BRCA1 and BRCA2 genes mutations: are personality traits involved?

Authors:  Anita Caruso; Cristina Vigna; Valentina Bigazzi; Carlo Leone; Gabriella Maggi; Aline Martayan; Fabio M Sega; Francesco Cognetti; Antonella Savarese
Journal:  Fam Cancer       Date:  2011-09       Impact factor: 2.375

7.  Breast self-examination in long-term breast cancer survivors.

Authors:  Peter C Trask; Lynne Pahl; Melinda Begeman
Journal:  J Cancer Surviv       Date:  2008-09-23       Impact factor: 4.442

8.  Patient preferences and National Health Service costs: a cost-consequences analysis of cancer genetic services.

Authors:  Gethin L Griffith; Rhiannon Tudor Edwards; J Mark G Williams; Jonathon Gray; Val Morrison; Clare Wilkinson; Jim Turner; Barbara France; Paul Bennett
Journal:  Fam Cancer       Date:  2008-09-27       Impact factor: 2.375

9.  The withdrawal from oncogenetic counselling and testing for hereditary and familial breast and ovarian cancer. A descriptive study of an Italian sample.

Authors:  Anita Caruso; Cristina Vigna; Gabriella Maggi; Fabio Massimo Sega; Francesco Cognetti; Antonella Savarese
Journal:  J Exp Clin Cancer Res       Date:  2008-11-24

10.  Changes in psychological distress after cancer genetic counselling: a comparison of affected and unaffected women.

Authors:  A Bish; S Sutton; C Jacobs; S Levene; A Ramirez; S Hodgson
Journal:  Br J Cancer       Date:  2002-01-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.